期刊名称：NEUROTOXICITY RESEARCH
 期刊简介(About the journal)
投稿须知(Instructions to Authors)
编辑部信息(Editorial Board)
About the journal
Neurotoxicity Research is an international, interdisciplinary broad-based journal for reporting both basic
and clinical research on classical neurotoxicity mechanisms associated with neurodegeneration, necrosis,
neuronal apoptosis, nerve regeneration, neurotrophin mechanisms, and topics related to these themes.
Published papers have focused on:
NEURODEGENERATION and INJURY
Neuropathologies
Neuronal apoptosis
Neuronal necrosis
Mechanisms of neural death processes (anatomical, histochemical, neurochemical)
Neurodegenerative Disorders: Parkinson’s, Huntington’s, Alzheimer’s Disease, ALS
Neural Effects of Substances of Abuse
NERVE REGENERATION and RESPONSES TO INJURY
Neural Adaptations
Neurotrophin mechanisms and actions
NEURO(CYTO)TOXICITY PROCESSES and NEUROPROTECTION
Excitatory amino acids and neurotoxic potential
Neurotoxins, endogenous and synthetic
Reactive oxygen (nitrogen) species formation in vivo and in vitro
Neuroprotective mechanisms; endogenous and exogenous neuroprotectant actions
Papers on related themes are welcome.
Publication History of Neurotoxicity Research
Neurotoxicity Research has been published continuously since 1999, originally by Gordon & Breach
Publishers. The journal was produced in 2002 by Taylor & Francis, and since 2003, by FP Graham
Publishing Co. Volume 6 for year 2004 will consist of eight (8) issues.
Instructions to Authors
Manuscripts. All papers are peer-reviewed. Manuscripts must be original, must not have appeared in another publication, and must not be dually submitted. Please submit three (3) copies of a manuscript, single-sided and double spaced plus an electronic file in Word8 to:
Richard M. Kostrzewa, Ph.D.
Editor, Neurotoxicity Research
Professor, Department of Pharmacology (PO Box 70577)
Quillen College of Medicine
East Tennessee State University
Rm 1-44, Bldg #1 on Dogwood Lane at VA Mtn. Home
Johnson City, TN 37614-1708, USA
PH: +1 423 439-6321 ?FAX: +1 423 439-8773 ?kostrzew@etsu.edu
The title page with author names should include all correspondence details. Pages must be numbered. Figures and Tables should be at the back of the manuscript, not within the text.
Types of Contributions. Full-length research papers should generally be 10,000 words or fewer. Clinical reports providing insight into neurodgenerative and neuroreparative processes will be accepted for review. Short Communications should be 2,500 words or less with up to three figures or tables and a maximum of 12 references. Reviews should generally be 12,000 words or less. Authors are required to secure written permission from the Copyright Holder for republication of figures, tables, or running text in all articles submitted for review.
Electronic Files. The printed copy of a paper must exactly match the electronic file. Do not save disk files as "read only".
Tables and Figures. Each table and figure should be on a separate page. Tables should be numbered with Roman numerals; figures, by Arabic numerals. The maximum space on a page for illustrations is 135 x 215 mm. Lettering, after reduction, must be at least 2 mm high. Please provide copy-ready versions of all artwork and illustrations. When possible, electronic files of figures should also be submitted, preferably as TIFF files. JPEG and other formats are also acceptable. Costs for color illustrations must be borne by the author ($300 per printed page).
Suitable symbols: 
References are cited in the text by author name (e.g., Smith, 1999; Smith and Jones, 2000; Smith et al., 2001; Smith et al., 2002a,b). The Reference List should be alphabetical in the style shown:
Kostrzewa RM, JP Kostrzewa and R Brus (2000) Dopaminergic denervation enhances susceptibility to hydroxyl radicals in rat neostriatum. Amino Acids 191, 183-199.
Kostrzewa RM (2001) Mechanisms of action of 6-hydroxydopamine, a dopaminergic neurotoxin, In: Segura-Aguilar J (Ed.), Mechanisms of Degeneration and Protection of the Dopaminergic System (FP Graham Publ. Co., Mountain Home, TN, USA), pp. 85-104.
Copyright agreement forms will be sent to all authors.
Editorial Board
EDITOR-IN-CHIEF
Richard M. Kostrzewa, Dept. Pharmacology, Quillen Col. Medicine, East Tennessee State Univ., Johnson City, TN, USA
ASSOCIATE EDITORS
Mario Herrera-Marschitz, Dept. Physiology & Pharmacology, Karolinska Institute, Stockholm, Sweden;
and Program of Molecular & Clinical Pharmacology, Univ. Chile, Santiago, Chile
Xin-Fu Zhou, Dept. Human Physiology, Flinders Univ. So. Australia, Adelaide Australia
EDITORIAL BOARD
Gjumrakch Aliev, Microscopy Research Center, Institute of Pathology, Case Western Reserve Univ., Cleveland, OH, USA
Trevor Archer, Department of Psychology, University of Göteborg, Göteborg, Sweden
Richard J Beninger, Department of Psychology, Queen’s Univ., Kingston ON Canada
C. LeRoy Blank, Dept. Chemistry & Biochemistry, Univ. Oklahoma, Norman, OK, USA
Ryszard Brus, Dept. Pharmacology, Medical University of Silesia, Zabrze, Poland
D. Allan Butterfield, Dept. Chemistry, University of Kentucky, Lexington, KY, USA
Jean Lud Cadet, Molecular Neuropsychiatry Section, NIDA, Baltimore, MD, USA
Neal Castagnoli, Jr., Dept. Chemistry, Virginia Tech, Blacksburg, VA, USA
Rudy Castellani, Dept. Neuropathology, Michigan State Univ., East Lansing, MI, USA
Sandra Ceccatelli, Div. Toxicology & Neurotoxicology, Inst. Environmental Medicine, Karolinska Inst., Stockholm, Sweden
Thomas N. Chase, NINCDS/NIH, Bethesda, MD, USA
Cyrus R. Creveling, NIDDK/NIH, Bethesda, MD, USA
Stanislaw Czuczwar, Dept. Pharmacol. & Toxicol., Lublin Medical Univ., Lublin, Poland
Wojciech Danysz, Dept. Behav. Pharmacol., Merz+Co., Frankfurt am Main, Germany
Glenn Dryhurst, Dept. Chemistry & Biochemistry, Univ. Oklahoma, Norman, OK, USA
Howard E. Gendelman, Ctr. Neurovirology & Neurodegenerative Disorders, Univ. Nebraska Med. Ctr., Omaha, NE, USA
Mark Geyer, Dept. Psychiatry & Neurosciences, Univ. California, San Diego, CA, USA
Ellen J. Hess, Depts. Neurology & Neuroscience, Johns Hopkins Univ. Baltimore, MD, USA
Hrissanthi Ikonomidou, Neuropaediatrie Kinderklinik, Humboldt Univ., Berlin, Germany
David M. Jacobowitz, Dept. Anatomy, Uniformed Services Univ., Bethesda, MD, USA
Jeffrey N. Joyce, Christopher Ctr., Sun Health Res. Inst., Sun City, AZ, USA
Kristen A. Keefe, Dept. Pharmacol. & Toxicol., Univ. Utah, Salt Lake City, UT, USA
J. William Langston, Parkinson’s Institute, Sunnyvale, CA, USA
Johan Luthman, Discovery Res Area, CNS & Pain Control, AstraZeneca R&D Sodertalje, Huddinge, Sweden
Mark Mattson, Chief, Laboratory of Neurosciences, NIA/NIH, Baltimore, MD, USA
Italo Mocchetti, Dept. Neuroscience, Georgetown University, Washington DC, USA
Micaela Morelli, Department of Toxicology, University of Cagliari, Cagliari, Italy
Hitoshi Okamura, Dept. Brain Sciences, Kobe Univ. Grad. Sch. Medicine, Kobe, Japan
Tomas Palomo, Fundación Cerebro y Mente, Madrid, Spain
Vijayalakshmi Ravindranath, National Brain Research Centre, Gurgaon, Haryana, India
George A. Ricaurte, Johns Hopkins Medical Inst., Baltimore, MD, USA
Peter Riederer, Clinic/Polyclinic, Psychiatry & Psychotherapy, Univ. Wuerzburg, Germany
Paul R Sanberg, Dept. Neurosurgery, Univ. So. Florida Col. Medicine, Tampa, FL, USA
Werner Schmidt, Dept. Zoologisches Inst., Abt. Neuropharmakol., Univ. Tuebingen, Germany
Rainer K.W. Schwarting, Exp. Physiol. Psychol., Philipps-Univ. of Marburg, Germany
Juan Segura-Aguilar, Prgm. Farmacol. Molec. Clinica, Univ. Chile, Santiago, Chile
David H. Small, Lab. Mol. Neurobiology, Dept. Biochemistry & Molecular Biology, Monash Univ., Victoria, Australia
Mark A. Smith, Institute of Pathology, Case Western Reserve Univ. Cleveland, OH, USA
John Smythies, Ctr. Brain & Cognition, Dept. Psychology, Univ. California, La Jolla, CA, USA;
Pierre Sokoloff, Unit?de Neurobiologie et Pharmacologie Moléculaire, INSERM, Paris, France
Peter S. Spencer, Ctr., Res. on Occupational & Environ. Toxicology, Oregon Health & Science Univ., Portland, OR, USA
David Sulzer, Depts. Psychiatry & Neurology, Columbia Univ., New York NY, USA
Matthew J. Wayner, Div. Life Sciences, Univ. Texas at San Antonio, TX, USA
Moussa B. Youdim, Dept. Pharmacol., Technion-Fac. Med., Rappaport Ctr., Haifa, Israel
|
